Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William B Messer

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Scientific Reports|December 8, 2017
Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4Douglas G Widman, Ellen Young, Usha Nivarthi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2012
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virionsRuklanthi de Alwis, Scott A Smith, Nicholas P Olivarez, et al.
Virology|March 15, 2013
Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunityAnna P Durbin, Sandra V Mayer, Shannan L Rossi, et al.
Plos Neglected Tropical Diseases|March 13, 2023
Infection with chikungunya virus confers heterotypic cross-neutralizing antibodies and memory B-cells against other arthritogenic alphaviruses predominantly through the B domain of the E2 glycoproteinJohn M Powers, Zoe L Lyski, Whitney C Weber, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2014
Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunityWilliam B Messer, Ruklanthi de Alwis, Boyd L Yount, et al.
Journal of Virology|March 11, 2016
Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1William B Messer, Boyd L Yount, Scott R Royal, et al.
Nature Communications|July 23, 2020
A global lipid map defines a network essential for Zika virus replicationHans C Leier, Jules B Weinstein, Jennifer E Kyle, et al.
Vaccines|August 29, 2024
The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ<sup>®</sup>) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural InfectionWhitney C Weber, Zachary J Streblow, Craig N Kreklywich, et al.
Med (New York, N.Y.)|September 9, 2025
Dengue virus infection reprograms baseline innate immune gene expressionEugenia Z Ong, Jia Xin Yee, Clara W Koh, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serumTimothy A Bates, Hans C Leier, Zoe L Lyski, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Scientific Reports|December 8, 2017
Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4Douglas G Widman, Ellen Young, Usha Nivarthi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2012
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virionsRuklanthi de Alwis, Scott A Smith, Nicholas P Olivarez, et al.
Virology|March 15, 2013
Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunityAnna P Durbin, Sandra V Mayer, Shannan L Rossi, et al.
Plos Neglected Tropical Diseases|March 13, 2023
Infection with chikungunya virus confers heterotypic cross-neutralizing antibodies and memory B-cells against other arthritogenic alphaviruses predominantly through the B domain of the E2 glycoproteinJohn M Powers, Zoe L Lyski, Whitney C Weber, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2014
Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunityWilliam B Messer, Ruklanthi de Alwis, Boyd L Yount, et al.
Journal of Virology|March 11, 2016
Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1William B Messer, Boyd L Yount, Scott R Royal, et al.
Nature Communications|July 23, 2020
A global lipid map defines a network essential for Zika virus replicationHans C Leier, Jules B Weinstein, Jennifer E Kyle, et al.
Vaccines|August 29, 2024
The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ<sup>®</sup>) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural InfectionWhitney C Weber, Zachary J Streblow, Craig N Kreklywich, et al.
Med (New York, N.Y.)|September 9, 2025
Dengue virus infection reprograms baseline innate immune gene expressionEugenia Z Ong, Jia Xin Yee, Clara W Koh, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serumTimothy A Bates, Hans C Leier, Zoe L Lyski, et al.
Pageof 9